Global and China Ambrisentan Drug Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.

    This report elaborates on the current development of the Ambrisentan Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Glaxo Smith Kline Limited (United Kingdom)

    • Cipla Inc (India)

    • Par Pharmaceutical, Inc (United States)

    • Sigmapharm Laboratories, LLC (United States)

    • Mylan SAS (United States)

    • Gilead Sciences, Inc (United States)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • 5 mg Tablet

    • 10 mg Tablet

    Application:

    • Hospital

    • Drug store

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Ambrisentan Drug Industry Overview

      • 1.1.1 Ambrisentan Drug Market Scope and Market Segments

      • 1.1.2 Ambrisentan Drug Industry Characteristics

      • 1.1.3 Global and China Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Ambrisentan Drug Production Value and Growth Rate (2017-2028)

    • 1.2 Global Ambrisentan Drug Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 5 mg Tablet

      • 1.2.2 10 mg Tablet

    • 1.3 Global Ambrisentan Drug Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Drug store

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Ambrisentan Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Ambrisentan Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Ambrisentan Drug Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Ambrisentan Drug Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Ambrisentan Drug Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Ambrisentan Drug Industry Porter's Five Forces Model Analysis

      • 2.2.3 Ambrisentan Drug Industry PEST Analysis

    • 2.3 Ambrisentan Drug Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Ambrisentan Drug Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Ambrisentan Drug Industry

    Chapter 3 Global and China Ambrisentan Drug Market, by Manufacturer

    • 3.1 Global and China Ambrisentan Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Ambrisentan Drug Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Ambrisentan Drug Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Ambrisentan Drug Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Ambrisentan Drug Market Top 3 Players

    Chapter 4 Global and China Ambrisentan Drug Market, by Type (2017-2028)

    • 4.1 Ambrisentan Drug Market Trend, by Type

    • 4.2 Global Ambrisentan Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Ambrisentan Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Ambrisentan Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Ambrisentan Drug Price Trend, by Type (2017-2028)

    • 4.3 China Ambrisentan Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Ambrisentan Drug Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Ambrisentan Drug Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Ambrisentan Drug Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Ambrisentan Drug Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Ambrisentan Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Ambrisentan Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Ambrisentan Drug Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Ambrisentan Drug Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Ambrisentan Drug Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Ambrisentan Drug Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Ambrisentan Drug Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Ambrisentan Drug Market Analysis

    • 7.1 North America Ambrisentan Drug Market, by Type

    • 7.2 North America Ambrisentan Drug Market, by Application

    • 7.3 North America Ambrisentan Drug Market Analysis and Forecast, by Country

      • 7.3.1 United States Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Ambrisentan Drug Market Analysis

    • 8.1 Europe Ambrisentan Drug Market, by Type

    • 8.2 Europe Ambrisentan Drug Market, by Application

    • 8.3 Europe Ambrisentan Drug Market Analysis and Forecast, by Country

      • 8.3.1 Germany Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Ambrisentan Drug Market Analysis

    • 9.1 APAC Ambrisentan Drug Market, by Type

    • 9.2 APAC Ambrisentan Drug Market, by Application

    • 9.3 APAC Ambrisentan Drug Market Analysis and Forecast, by Country

      • 9.3.1 China Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Ambrisentan Drug Market Analysis

    • 10.1 Latin America, Middle East and Africa Ambrisentan Drug Market, by Type

    • 10.2 Latin America, Middle East and Africa Ambrisentan Drug Market, by Application

    • 10.3 Latin America, Middle East and Africa Ambrisentan Drug Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Ambrisentan Drug Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Ambrisentan Drug Company Profiles

      • 11.1 Glaxo Smith Kline Limited (United Kingdom)

        • 11.1.1 Glaxo Smith Kline Limited (United Kingdom) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Product Profiles, Application and Specification

        • 11.1.3 Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Cipla Inc (India)

        • 11.2.1 Cipla Inc (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Cipla Inc (India) Ambrisentan Drug Product Profiles, Application and Specification

        • 11.2.3 Cipla Inc (India) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Par Pharmaceutical, Inc (United States)

        • 11.3.1 Par Pharmaceutical, Inc (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Par Pharmaceutical, Inc (United States) Ambrisentan Drug Product Profiles, Application and Specification

        • 11.3.3 Par Pharmaceutical, Inc (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Sigmapharm Laboratories, LLC (United States)

        • 11.4.1 Sigmapharm Laboratories, LLC (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Product Profiles, Application and Specification

        • 11.4.3 Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Mylan SAS (United States)

        • 11.5.1 Mylan SAS (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Mylan SAS (United States) Ambrisentan Drug Product Profiles, Application and Specification

        • 11.5.3 Mylan SAS (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Gilead Sciences, Inc (United States)

        • 11.6.1 Gilead Sciences, Inc (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Gilead Sciences, Inc (United States) Ambrisentan Drug Product Profiles, Application and Specification

        • 11.6.3 Gilead Sciences, Inc (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Ambrisentan Drug Industry Investment Prospect and Risk Assessment

    • 12.1 Ambrisentan Drug Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Ambrisentan Drug Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Global Ambrisentan Drug Production Value and Growth Rate (2017-2028)

    • Figure China Ambrisentan Drug Production Value and Growth Rate (2017-2028)

    • Figure Global Ambrisentan Drug Market Size and Growth Rate of 5 mg Tablet (2017-2028)

    • Figure Global Ambrisentan Drug Market Size and Growth Rate of 10 mg Tablet (2017-2028)

    • Figure Global Ambrisentan Drug Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Ambrisentan Drug Market Size and Growth Rate of Drug store (2017-2028)

    • Figure North America Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Ambrisentan Drug Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Ambrisentan Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Ambrisentan Drug Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Ambrisentan Drug Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Ambrisentan Drug Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Ambrisentan Drug Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Ambrisentan Drug Market Share, by Manufacturer in 2021

    • Figure Global and China Ambrisentan Drug Market Share, by Manufacturer in 2022

    • Table Global Ambrisentan Drug Sales Volume, by Type (2017-2028)

    • Table Global Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Figure Global Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Table Global Ambrisentan Drug Sales Value, by Type (2017-2028)

    • Table Global Ambrisentan Drug Sales Value Share, by Type (2017-2028)

    • Figure Global Ambrisentan Drug Price Trend, by Type (2017-2028)

    • Table China Ambrisentan Drug Sales Volume, by Type (2017-2028)

    • Table China Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Figure China Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Table China Ambrisentan Drug Sales Value, by Type (2017-2028)

    • Table China Ambrisentan Drug Sales Value Share, by Type (2017-2028)

    • Figure China Ambrisentan Drug Price Trend, by Type (2017-2028)

    • Table Global Ambrisentan Drug Sales Volume, by Application (2017-2028)

    • Table Global Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure Global Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Table Global Ambrisentan Drug Sales Value, by Application (2017-2028)

    • Table Global Ambrisentan Drug Sales Value Share, by Application (2017-2028)

    • Figure Global Ambrisentan Drug Sales Value Share, by Application (2017-2028)

    • Table China Ambrisentan Drug Sales Volume, by Application (2017-2028)

    • Table China Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Table China Ambrisentan Drug Sales Value, by Application (2017-2028)

    • Table China Ambrisentan Drug Sales Value Share, by Application (2017-2028)

    • Figure China Ambrisentan Drug Sales Value Share, by Application (2017-2028)

    • Figure China Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • Figure North America Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Ambrisentan Drug Production, Import, Consumption and Export (2017-2022)

    • Table North America Ambrisentan Drug Sales Volume, by Type (2017-2028)

    • Table North America Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Figure North America Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Table North America Ambrisentan Drug Sales Volume, by Application (2017-2028)

    • Table North America Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure North America Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure United States Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure United States Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Canada Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Table Europe Ambrisentan Drug Sales Volume, by Type (2017-2028)

    • Table Europe Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Figure Europe Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Table Europe Ambrisentan Drug Sales Volume, by Application (2017-2028)

    • Table Europe Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure Europe Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure Germany Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure UK Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure UK Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure France Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure France Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Italy Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Spain Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Poland Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Russia Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Table APAC Ambrisentan Drug Sales Volume, by Type (2017-2028)

    • Table APAC Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Figure APAC Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Table APAC Ambrisentan Drug Sales Volume, by Application (2017-2028)

    • Table APAC Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure APAC Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure China Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure China Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Japan Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure India Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure India Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Ambrisentan Drug Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Ambrisentan Drug Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Ambrisentan Drug Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Ambrisentan Drug Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Ambrisentan Drug Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Ambrisentan Drug Sales Value and Growth Rate (2017-2028)

    • Table Glaxo Smith Kline Limited (United Kingdom) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Glaxo Smith Kline Limited (United Kingdom) Product Profiles, Application and Specification

    • Table Glaxo Smith Kline Limited (United Kingdom) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cipla Inc (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cipla Inc (India) Product Profiles, Application and Specification

    • Table Cipla Inc (India) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Par Pharmaceutical, Inc (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Par Pharmaceutical, Inc (United States) Product Profiles, Application and Specification

    • Table Par Pharmaceutical, Inc (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sigmapharm Laboratories, LLC (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sigmapharm Laboratories, LLC (United States) Product Profiles, Application and Specification

    • Table Sigmapharm Laboratories, LLC (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mylan SAS (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mylan SAS (United States) Product Profiles, Application and Specification

    • Table Mylan SAS (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Sciences, Inc (United States) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Sciences, Inc (United States) Product Profiles, Application and Specification

    • Table Gilead Sciences, Inc (United States) Ambrisentan Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.